Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Interaction of MCI-154 and isoflurane on myocardial contractility and hemodynamics

Oct. 25, 2000

FDA grants priority review status for pulmonary hypertension NDA

Oct. 23, 2000

Taisho presents new series of vasodilators

Oct. 20, 2000

NicOx designs improved antiinflammatory, analgesic and antithrombotic compounds

Oct. 19, 2000

NCX-4016 superior to aspirin in reducing myocardial infarct size in animal model

Oct. 19, 2000

Nonpeptide Y1 antagonist H-409/22 examined for in vivo effects on vascular responses

Oct. 19, 2000

AstraZeneca licenses antiarrhythmic drug candidate from Nortran

Oct. 19, 2000

Nortran's new ion channel blockers useful as antiarrhythmics

Oct. 18, 2000

Esperion acquires biotechnology company; LUV program proceeds ahead of schedule

Oct. 18, 2000

Potent Na+/H+ exchange inhibitor TY-12533 displays excellent cardioprotective profile in vivo

Oct. 18, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...